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ABSTRACT 42 
In patients with combined obesity and chronic obstructive pulmonary disease (COPD), 43 
dyspnea intensity at matched work rates during weight-supported cycling and weight-44 
bearing walking is similar, despite consistent metabolic differences between test 45 
modalities. The current study examined the influence of differences in activity of the 46 
diaphragm and abdominal muscles during cycling and walking on intensity and quality of 47 
dyspnea at matched ventilation in obese patients with COPD. We compared respiratory 48 
muscle activity patterns and dyspnea ratings during incremental cycle and treadmill 49 
exercise tests, where work rate was matched, in twelve obese (body mass index 50 
36.6±5.4kg/m2; mean±SD) patients with moderate COPD. We used a multi-pair electrode-51 
balloon catheter to compare electromyography of the diaphragm and esophageal, gastric 52 
and trans-diaphragmatic pressures during the two exercise tests. Ventilation, breathing 53 
pattern, operating lung volumes, global respiratory effort and electrical activation of the 54 
diaphragm were similar across exercise modalities for a given work rate.  The cycling 55 
position was associated with greater neuromuscular efficiency of the diaphragm (p<0.01), 56 
greater diaphragm use (p<0.01) measured by the ventilatory muscle recruitment index and 57 
less expiratory muscle activity compared (p<0.01) to treadmill walking. However, intensity 58 
and quality of dyspnea were similar between exercise modalities. In obese patients with 59 
COPD, altered respiratory muscle activity due to body position differences between cycling 60 
and walking did not modulate perceived dyspnea when indirect measures of respiratory 61 
neural drive were unchanged.  62 
 63 
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INTRODUCTION 66 
It is believed that exertional dyspnea intensity in patients with chronic obstructive 67 
pulmonary disease (COPD) rises in association with increased central motor command 68 
output to the respiratory muscles (15,19,27,40) and can be  further modulated by altered 69 
afferent inputs from peripheral sensory receptors in the lungs, respiratory muscles and 70 
chest wall (32,34,37). In patients with combined COPD and obesity, activity-related 71 
dyspnea is a major symptom and likely contributes to poor health-related quality of life 72 
(45). The prevalence of both COPD and obesity is increasing at an alarming rate throughout 73 
the world and improved symptom control in this sub-population with combined disorders 74 
awaits a better understanding of how excessive weight interacts with the basic 75 
pathophysiology of COPD (14,30). Studies have shown that dyspnea in obese patients with 76 
moderate-to-severe COPD is multifactorial and we have argued that increased metabolic 77 
requirements (increased carbon dioxide output) related to excessive body weight, which 78 
drive increased ventilation during physical activity, are more important than respiratory 79 
mechanical factors, per se, in contributing to exertional dyspnea (30,38).   80 
In a recent non-invasive study in obese COPD patients, we established that 81 
dyspnea/work rate and dyspnea/ventilation slopes were not affected by exercise test 82 
modality (cycling versus walking when work rate was controlled) despite consistent inter-83 
modality differences in some metabolic factors, e.g., oxygen uptake (VO2) and arterial 84 
oxygen saturation (8).  In the current study, we extend our previous work in obese COPD 85 
by examining, for the first time, the effect of potential differences in amplitude of central 86 
respiratory drive (measured indirectly by diaphragmatic electromyography) and 87 
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respiratory muscle activity (measured by esophageal and gastric balloons) between 88 
exercise modalities on dyspnea across its intensity, quality and affective dimensions.  89 
A number of studies in non-obese healthy individuals have documented 90 
compensatory adjustments in abdominal muscle activity to preserve diaphragmatic 91 
function when adopting a standing body position (10,11,23,26,47).  Such studies have, to 92 
our knowledge, not been conducted during rest or exercise in obese individuals with COPD.  93 
It is reasonable to assume that these normal compensatory adjustments to standing 94 
upright may be undermined by exaggerated gravitational effects of abdominal obesity. 95 
Thus, it is possible that diaphragmatic function may be more compromised during standing 96 
and walking (compared with weight-supported cycling) in obese patients and this may 97 
have negative sensory consequences. The corollary is that relatively improved 98 
diaphragmatic function during cycling would be associated with favourable effects on 99 
dimensions of dyspnea as has previously been shown in non-obese COPD patients after 100 
interventions that improve respiratory muscle function (e.g., leaning forward position, 101 
bronchodilators, non-invasive mechanical ventilation) (12,33,37). Accordingly, our 102 
objectives were to determine if: 1) diaphragmatic function, expiratory muscle activity and 103 
respiratory muscle recruitment pattern was different during walking and cycling in obese 104 
COPD patients, and 2) whether such inter-modality differences in respiratory muscle 105 
activity (and accompanying afferent inputs from muscle mechanoreceptors) had direct 106 
sensory consequences when external power output was standardized between tests. We 107 
therefore compared indirect indices of central respiratory drive, esophageal and 108 
transdiaphragmatic pressures, diaphragmatic efficiency and intensity, quality and affective 109 
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components of dyspnea during incremental treadmill and cycle exercise when work rate 110 
was carefully matched.   111 
112 
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METHODS 113 
Subjects 114 
Twelve clinically stable obese (body mass index (BMI) >30 kg/m2) patients with COPD 115 
(FEV1/FVC <70%) and a post-bronchodilator FEV1 <80% predicted were included. 116 
Exclusion criteria included: a significant disease (i.e. metabolic, cardiovascular, 117 
neuromuscular and/or musculoskeletal) which could affect breathlessness or exercise 118 
capacity, daytime oxygen therapy, a respiratory disease other than COPD, too breathless to 119 
leave the house or not breathless (Medical Research Council (MRC) dyspnea scale 5 or 1, 120 
respectively), and any contraindications to clinical exercise testing (3). 121 
 122 
Study Design 123 
This cross-sectional study received ethical approval from Queen’s University and Affiliated 124 
Hospitals Research Ethics Board (DMED-1187-09). Patients attended 3 visits separated by 125 
at least 48 hours. Visit 1 included medical screening, detailed pulmonary function tests, and 126 
familiarization with all exercise testing procedures. At visits 2 and 3, patients were 127 
randomized to perform either a cycle or treadmill test with detailed EMGdi and pressure-128 
derived respiratory mechanical measurements. Before each visit, patients were instructed 129 
to withhold inhaler medication at least 4 hours for short-acting β2-agonists, 6 hours for 130 
anticholinergics and 12 hours for long-acting bronchodilators. Patients were asked to 131 
refrain from the intake of caffeine, heavy meals, alcohol and from major physical exertion 132 
prior to each visit. At a separate visit, patients underwent dual-energy x-ray 133 
absorptiometry (DEXA) scans to quantify body composition. 134 
 135 
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Procedures 136 
Pulmonary function testing included routine spirometry, body plethysmography, single-137 
breath diffusing capacity for carbon monoxide (DLCO), maximum inspiratory and 138 
expiratory mouth pressures, static lung compliance (CLst) and static lung recoil pressure 139 
(PLst) using automated testing equipment (Vs62j body plethysmograph with Vmax229d; 140 
SensorMedics, Yorba Linda, CA). Cardiopulmonary exercise tests were performed on an 141 
electronically braked cycle ergometer (Ergometrics 800S; SensorMedics, Yorba Linda, CA) 142 
and on a treadmill (MedTrack ST55; Quinton Instrument, Bothell, WA) using a Vmax229d 143 
Cardiopulmonary Exercise Testing System (SensorMedics). Cycle and treadmill exercise 144 
tests were both performed with 10-watt increments which increased every two minutes to 145 
a symptom-limited peak. The treadmill work rate was adjusted as follows:  speed began at 146 
0.8 miles/hour (21.46 m/min) and thereafter increased linearly by 0.2 miles/hour (5.36 147 
m/min) for every 10W increment for all subjects; a curvilinear rise in percent grade was 148 
calculated for each subject based on the equation by Cooper and Storer [watts= 0.1634 × 149 
speed(m/min) × %grade/100 × body mass(kg)] (9). Breath-by-breath data 150 
(cardiopulmonary, EMGdi and respiratory-mechanical measurements) were analyzed 151 
using 30-s averages from each individual at steady-state rest, the first 30-s interval of the 152 
last minute from each exercise work rate and the last 30-s of loaded pedaling (peak). 153 
Inspiratory capacity (IC) maneuvers were performed during the steady-state resting 154 
period, during the last 30-s of each exercise work rate and at peak exercise. Operating lung 155 
volumes were derived from IC measurements (36): end-expiratory lung volume (EELV)= 156 
total lung capacity (TLC) - IC, end-inspiratory lung volume (EILV)= EELV + tidal volume 157 
(VT), and inspiratory reserve volume (IRV)= IC-VT. Subjects rated “breathing discomfort,” 158 
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“leg discomfort,” “work or effort of breathing,” “difficulty breathing in” and “ how 159 
unpleasant or bad is your breathing” on a modified 10-point Borg scale at rest, every two 160 
minutes of exercise and at peak exercise (4,39). Immediately after exercise, subjects were 161 
asked why they stopped exercising. 162 
 163 
Diaphragm EMG and Respiratory Pressures 164 
A combined EMGdi electrode catheter with esophageal and gastric balloons was inserted 165 
nasally and positioned according to the strength of inspiratory EMGdi recordings, i.e., 166 
position was optimal when the amplitude of the outer of the 5 electrode pairs was greatest 167 
and the middle electrode pair was lowest (22). The raw EMGdi signal was amplified and 168 
band-pass filtered between 20-1000 Hz (Bioamplifier model RA-8; Guanzhou Yinghui 169 
Medical Equipment Co. Ltd, Guangzhou, China) then sampled at 2000 Hz (PowerLab, model 170 
ML880; ADInstruments, CastleHill, NSW, Australia). This signal was converted to a root 171 
mean square and averaged during inspiration between cardiac QRS complexes using a 172 
100ms time constant and a moving window. The largest value from the five electrode pairs 173 
was representative of each inspiration. The highest EMGdi value from either resting/peak 174 
sniff maneuvers or resting and exercise IC measurements was used as the maximum EMGdi 175 
(EMGdi,max). 176 
The esophageal and gastric balloons were inflated with 1.0 mL and 1.2 mL of air, 177 
respectively, and connected to differential pressure transducers (model DP15-34; Validyne 178 
Engineering, Northridge, CA, USA). Esophageal (Pes) and gastric pressures (Pga) were 179 
continuously recorded at a rate of 200 Hz (PowerLab). Transdiaphragmatic pressure (Pdi) 180 
was recorded as the difference between Pga and Pes signals. The PowerLab system 181 
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received continuous flow signal input from the Vmax229d cardiopulmonary testing system 182 
for offline analysis.  183 
Pre- and post-exercise inspiratory sniffs were performed to obtain maximum Pes 184 
(Pes,sn) and Pdi (Pdi,sn). IC maneuvers at rest and throughout exercise were used to obtain 185 
dynamic peak inspiratory Pes (Pes,IC) and Pdi (Pdi,IC). Pre- and post-exercise FVC 186 
maneuvers were also performed to obtain dynamic peak expiratory Pes (Pes,FVC). Tidal 187 
Pes swings (Pes,tidal) were defined as the amplitude between the maximum expiratory 188 
value (Pes,exp) and minimum inspiratory value (Pes,insp) for each respiratory cycle, and 189 
expressed relative to maximum Pes (Pes,max: difference between Pes,IC and Pes,FVC). 190 
Similarly, tidal Pdi swings (Pdi,tidal) were defined as the excursion between maximum 191 
inspiratory (Pdi,insp) and minimum Pdi during expiration. The inspiratory rise in Pdi 192 
(Pdi,insp.rise) was defined as the increase in Pdi from the onset of inspiratory flow to peak 193 
Pdi during inspiration. The peak tidal expiratory Pga (Pga,exp) and expiratory rise in Pga 194 
(Pga,exp.rise), which is the increase in Pga from the lowest point after onset of expiratory 195 
flow to its peak value during expiration, were used to estimate expiratory muscle activation 196 
(40). End-inspiratory (EI) and end-expiratory (EE) data points of zero flow for Pes and Pga 197 
were collected. The ventilatory muscle recruitment (VMR) index was calculated as the 198 
difference between Pga,EI and Pga,EE divided by the difference between Pes,EI and Pes,EE 199 
(29): a negative value represents greater diaphragm contribution and a positive value 200 
represents a greater ribcage muscle contribution to inspiration. Finally, neuromuscular 201 
efficiency of the diaphragm was defined as the relation between inspiratory rise Pdi 202 
(Pdi,insp.rise) and EMGdi/EMGdi,max.   203 
 204 
Statistical Analysis 205 
10 
This study had a small sample size due to the complexity and invasiveness of the respiratory 206 
pressure/EMGdi measurements. However, in a previous study evaluating similar outcome 207 
measures, a sample size of 11 was sufficient to show significant within-subject differences in 208 
sensory and respiratory mechanical/EMGdi measurements at a standardized work rate across two 209 
conditions (22). Comparisons of exercise modalities were made at rest, at standardized work 210 
rates (i.e., 10, 20, 30 and 40 watts) and at peak exercise using paired two-tailed t-tests. 211 
Linear interpolation was used to calculate Pdi,insp.rise for both tests at common levels of 212 
EMGdi/EMGdi,max (i.e., 30, 40 and 50 %). A two-way ANOVA for repeated measures was 213 
used to an analyze measurements of respiratory muscle strength pre- and post-exercise 214 
across test modalities. To evaluate the relationship between dyspnea intensity (dependent 215 
variable) and relevant independent variables during exercise, the following were included 216 
in a multivariable linear regression model: the independent variable of interest, exercise 217 
modality as a categorical effect, an interaction term to determine whether the relationship 218 
being tested was similar across test modality (independent variable*modality), and 219 
subjects were treated as random effects to account for serial measurements (subject nested 220 
within modality). Results are reported as means ± SD unless specified otherwise. A p<0.05 221 
was used for statistical significance. 222 
 223 
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RESULTS 224 
Subject characteristics and resting pulmonary function are presented in Table 1. Subjects 225 
fit either GOLD 2 (n=9) or GOLD 3 (n=3) spirometric criteria for moderate or severe airflow 226 
obstruction, respectively (44). By GOLD recommendations, all subjects were symptomatic 227 
(category B or D) with either a modified MRC grade ≥2 or a COPD Assessment Test (CAT) 228 
score ≥10 (44). The mean BMI fell within the Class II obesity classification which is 229 
associated with a “very high disease risk” when combined with a waist circumference 230 
>88cm in women and >102cm in men (46). Waist circumference was elevated by 22cm in 231 
males and 25cm in females relative to previously defined abdominal obesity criteria 232 
(16,46). DEXA scans were available in 9 subjects and revealed that males (n=4) and females 233 
(n=5) had a similar mean percentage of total body fat (40 and 42 %, respectively) and 234 
truncal fat (45 and 42 %, respectively) (Table 1).  235 
 236 
Exercise Responses 237 
Steady-state rest and peak exercise responses are reported in Table 2. Patients exercised 238 
to a peak work rate of 73±17 watts on the cycle ergometer and 78±22 watts on the 239 
treadmill (p=0.27). Exercise duration was longer on the treadmill compared with the cycle 240 
ergometer by a mean difference of 67 seconds but was not significantly different (p=0.17). 241 
Peak oxygen uptake (VO2) during treadmill exercise was significantly higher compared to 242 
cycle exercise. VE (Figure 1A) and carbon dioxide production (VCO2) were similar at a 243 
given work rate and reached similar peak values (Table 2) for both exercise modalities. 244 
Moreover, VE/VCO2 relationships were superimposed across exercise modalities. For any 245 
given VE during exercise, both exercise modalities had similar EMGdi/EMGdi,max, global 246 
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respiratory muscle effort (Pes,tidal in absolute terms and relative to Pes,max), breathing 247 
pattern and operating lung volumes (Figure 1B and C).  248 
 249 
Inspiratory Muscles 250 
Raw data tracings from a representative patient are shown in Figure 2 to illustrate 251 
differences in Pga, Pdi and the VMR at a similar work rate (30W) and VE (cycle: 24 L/min; 252 
treadmill: 26 L/min). Indices of inspiratory muscle strength were not significantly different 253 
across modalities for pre- and post-exercise measurements when analyzed by two-way 254 
repeated measures ANOVA; however, post-exercise Pdi,IC and Pdi,sn decreased 255 
significantly from pre-exercise values with both modes of exercise (Table 3). Pes,insp in 256 
absolute terms or relative to Pes,IC was similar during exercise under both conditions 257 
(Figure 1C, Table 3). Pdi,insp was greater throughout cycle exercise compared to 258 
treadmill exercise (Figure 3A); however, inspiratory diaphragmatic effort (Pdi,insp/Pdi,IC) 259 
was similar between both exercise conditions due to a concurrent increase in Pdi,IC during 260 
cycle exercise. Pdi,insp.rise was also significantly greater during cycling compared with 261 
treadmill exercise (Figure 3B). Furthermore, the downward displacement of the VMR 262 
index during cycling indicates greater use of the diaphragm at rest and at any given work 263 
rate compared with treadmill exercise (Figure 3C). Interpolated values of Pdi,insp.rise at 264 
standardized EMGdi/EMGdi,max of 30, 40 and 50 % were greater during cycle compared to 265 
treadmill exercise, indicating increased diaphragm efficiency during cycling (Figure 4).  266 
 267 
Expiratory Muscles 268 
There was greater abdominal expiratory muscle activity during treadmill compared with 269 
cycle exercise as shown by a greater Pga,exp.rise throughout exercise and by a greater 270 
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proportion of subjects exhibiting a Pga,exp.rise at rest and early in exercise (Figure 3E and 271 
F). Pga,EE was similar during both modes of exercise, while Pga,EI fell to a significantly 272 
greater extent during treadmill walking compared to cycling (Figure 3D).  273 
 274 
Exertional Dyspnea 275 
Subjects reported similar intensity of “breathing discomfort” (Figure 5A), “work/effort of 276 
breathing,” “difficulty breathing in” and “unpleasantness of breathing” (Figure 5B) during 277 
submaximal and symptom-limited peak exercise for both test modalities. There were no 278 
significant differences between modalities for reasons for stopping exercise. Breathing 279 
discomfort, alone or in combination with leg discomfort, was reported as the main reason 280 
for stopping exercise in 58% of cycle tests and in 83% of treadmill tests. Conversely, leg 281 
discomfort, alone or in combination with breathing discomfort, was reported in 75% of 282 
cycle tests and in 58% of treadmill tests. Qualitative descriptors of breathlessness at end-283 
exercise were similar between modalities.  Dyspnea increased similarly in both tests as a 284 
function of increasing VE, EMGdi/EMGdi,max, and Pes,tidal/Pes,max throughout exercise 285 
(Figure 5).  Dyspnea intensity during exercise correlated strongly with VE/MVV, 286 
Pes,tidal/Pes,max and EMGdi/EMGdi,max (all p<0.0005); these relationships were similar 287 
across testing modality. 288 
 289 
14 
DISCUSSION 290 
The novel findings of this study were: 1) COPD patients with abdominal adiposity had 291 
greater diaphragmatic efficiency and less expiratory muscle activity when cycling 292 
compared with walking; and 2) differences in respiratory muscle recruitment to achieve a 293 
given ventilation during different exercise modalities did not impact intensity, affective and 294 
qualitative domains of dyspnea. Our results do not support the hypothesis that differences 295 
in afferent inputs from the diaphragm and expiratory muscles during walking versus 296 
cycling modulate dyspnea perception in obese patients with COPD, at least in 297 
circumstances where ventilation, indirect measures of respiratory neural drive and 298 
dynamic respiratory mechanics are similar across exercise modalities. 299 
Patients in this study had moderate airway obstruction and were moderately obese 300 
with significant abdominal adiposity (Table 1). Cardio-respiratory fitness expressed as 301 
peak VO2 relative to ideal body weight was only modestly reduced. Mechanical constraints 302 
on ventilation were similar at peak exercise, as was peak dyspnea intensity, and breathing 303 
discomfort was a predominant reason for stopping exercise during both modalities.  304 
 305 
Respiratory Muscle Adjustments to Test Modality 306 
Maintaining effective diaphragmatic function in the upright posture in humans requires a 307 
number of compensatory actions that include: increased EMGdi activation, together with 308 
increased activation of abdominal and ribcage intercostal muscles (10,11,23,26,47). 309 
Gravitational displacement of the abdominal viscera (on standing) is believed to stretch the 310 
abdominal wall and to activate abdominal muscles to maintain intra-abdominal volume 311 
and pressure (compliance), thereby improving the geometric and length-tension 312 
relationships of the diaphragm (10). Increased tonic activation of the diaphragm and 313 
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abdominal muscles has been described in healthy humans in the standing position during 314 
repetitive upper limb movement (20,21). The sensory consequences of this competition 315 
between the respiratory and trunk-stabilizing functions of the diaphragm and abdominal 316 
muscles during different lower limb exercises in patients with already compromised 317 
respiratory muscle function is unknown. In severely hyperinflated COPD, a reflexive 318 
increase in diaphragmatic and accessory muscle activity has been described in response to 319 
moving from the supine to the standing position (12). Whether such compensatory 320 
strategies exist in less hyperinflated patients such as ours with combined COPD and obesity 321 
(where IC is relatively preserved) has not been studied. To our knowledge, the current 322 
study is the first to determine if the presence of abdominal obesity in COPD further 323 
undermines these posture-compensating strategies to maintain effective respiratory 324 
function of the diaphragm during exercise. 325 
Resting comparisons prior to onset of exercise (cycling versus treadmill) showed 326 
small increases in Pdi,insp.rise, less accessory and expiratory muscle activity (more 327 
negative VMR) and modestly lower expiratory effort while sitting prior to cycling. At rest, 328 
there were no differences in tidal EMGdi or in diaphragmatic efficiency during sitting or 329 
standing. During cycling, obese COPD patients had greater Pdi,insp and greater peak force 330 
generating capacity (Pdi,IC) compared to treadmill exercise, suggesting a distinct 331 
mechanical advantage (Figure 3). Since efferent respiratory neural output 332 
(EMGdi/EMGdi,max) to the crural diaphragm was similar during both modalities, the 333 
greater Pdi,insp.rise pressures during cycling suggest greater neuromuscular efficiency of 334 
this muscle (Figure 4). Improved diaphragmatic efficiency (change in Pdi relative to change 335 
in EMGdi) during cycling may reflect relatively improved (reduced) abdominal compliance 336 
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in this posture allowing an enhanced fulcrum effect of increased abdominal impedance 337 
during diaphragmatic descent (11). A leaning forward position while seated with arms 338 
extended grasping the handlebars might improve length-tension relations of the 339 
diaphragm or permit the pectoral and scalene muscles to act as accessory muscles of 340 
inspiration (18,42), as has been previously proposed (11,12). However, our ergometer and 341 
mouthpiece assembly ensured an almost vertical position of the thorax during cycling 342 
suggesting that such factors are not instrumental in improving diaphragmatic efficiency in 343 
this circumstance. It is also possible that with hip flexion during cycling, the proximal 344 
thighs supported the lower abdominal wall during the breathing cycle, thus helping to 345 
maintain positive intra-abdominal hydraulic pressure to assist the diaphragms inspiratory 346 
action (1). 347 
During walking, neuromuscular efficiency of the diaphragm was significantly 348 
reduced compared with cycling. Prior to exercise and consistent with previous studies in 349 
health (26), most patients had phasic expiratory muscle activity (Pga,exp.rise) while 350 
standing compared to sitting (91% vs 50%, respectively). However, on average, the 351 
magnitude of expiratory muscle activity was similar in both cycle and treadmill positions at 352 
rest. During treadmill walking there was a fall in Pga,EI (Figure 3) and a shift in the 353 
respiratory muscle recruitment pattern towards more activity of the inspiratory muscles of 354 
the ribcage and expiratory muscles as indicated by analysis of Macklem VMR plots (28). A 355 
reduction in Pga,EI and increased abdominal volume has been reported during cycle and 356 
treadmill exercise in separate studies in healthy individuals, and is thought to indicate 357 
abdominal wall relaxation during inspiration (2,41). Whether similar mechanisms are at 358 
play during walking in obese COPD patients could not be determined in the absence of 359 
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concomitant measures of thoraco-abdominal displacements. In contrast to the situation 360 
during treadmill exercise, Pga,EE and Pga,EI were similar in absolute terms throughout 361 
submaximal cycle exercise in our patients suggesting improved (decreased) abdominal 362 
compliance. In keeping with the results of a recent study (25), there was no difference in 363 
the behaviour of EELV despite the differences in expiratory muscle recruitment between 364 
modalities.  365 
Despite differences in respiratory muscle recruitment across tests, global 366 
measurements of respiratory muscle activity (tidal swings of Pes) were similar for a given 367 
ventilation. Individual respiratory muscle contributions to ventilation may vary such that 368 
reduced diaphragmatic contributions during treadmill is likely counterbalanced by 369 
increased contribution of other respiratory muscles to maintain the VE dictated by the 370 
VCO2.  Based on a previous study (25), we believe that the relatively increased expiratory 371 
muscle activity during treadmill testing in the current study is unlikely to translate into 372 
increased ventilatory output in the presence of expiratory flow limitation.  373 
A related question is why relatively increased diaphragmatic activity during cycling 374 
compared with walking did not translate into increased VE for a given work rate? In line 375 
with the argument above, one possibility is that increased diaphragmatic activity is linked 376 
to a corresponding reduction in activity of the other respiratory muscles (as suggested by 377 
our VMR analysis) such that VE, as dictated by the prevailing VCO2, remains constant. A 378 
second possibility is that even in the face of increased inspiratory muscle activity during 379 
cycling, further increases in VE are not possible, particularly at higher exercise intensities 380 
where significant restrictive respiratory mechanical constraints are present (Figure 1F).       381 
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The similarity in ventilatory response during the two exercise modalities, despite 382 
differences in the contribution of various respiratory muscles to support ventilation, is also 383 
explained by metabolic factors.  Thus, the ventilatory response to exercise, regardless of 384 
the test modality, was ultimately determined by VCO2.  As highlighted in our previous study 385 
(8), it is clear that net VCO2/work rate responses and VE/VCO2 (and consequent VE/work 386 
rate) slopes were similar across tests, notwithstanding differences in VO2 and RER.  387 
 388 
Mechanisms of Exertional Dyspnea 389 
Increased central neural drive. Current concepts of the neurophysiology of exertional 390 
dyspnea in COPD emphasize the key role of increased respiratory neural drive from 391 
cortical and medullary centers in the brain and the attendant increased central corollary 392 
discharge to the somatosensory cortex (35,39).  We extended the results of our previous 393 
study by demonstrating that not only ventilatory parameters but also respiratory neural 394 
drive (EMGdi/EMGdi,max) and global respiratory effort were similar during both exercise 395 
modalities and increased as a function of increasing VCO2.  Thus we confirmed that the 396 
association between dyspnea intensity and measures of central respiratory drive was 397 
independent of the VO2 requirements at a standardized external power output during 398 
walking and cycling. The strong correlations (independent of exercise modality) between 399 
dyspnea intensity and the three indirect indices of increasing respiratory neural drive (i.e., 400 
VE/MVV, EMGdi/EMGdi,max and effort and Pes,tidal/Pes,max) support the hypothesis that 401 
amplitude of central respiratory drive (and central corollary discharge) is an important 402 
determinant of dyspnea regardless of the nature of the physical task that provokes the 403 
symptom.  404 
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Altered afferent sensory inputs. The previously established relationship between 405 
increase in dyspnea intensity and reduction of dynamic IRV towards its minimal value (33) 406 
has been shown to be independent of exercise modality (8). It is widely accepted that 407 
alteration of peripheral afferent inputs from the respiratory system (lung, chest wall and 408 
respiratory muscles), can influence dimensions of dyspnea during exercise. For example, 409 
increased VT and IRV following pharmacological lung deflation, or changes in posture at 410 
rest, can affect (reduce) activity-related dyspnea intensity perception, presumably by 411 
altering peripheral afferent sensory inputs from the respiratory system and by partially 412 
reducing neuromechanical dissociation (32). It has long been postulated that afferent 413 
information from abundant sensory receptors in the respiratory muscles represents the 414 
proximate source of feedback regarding the status of the respiratory system and the 415 
appropriateness of its response to the prevailing central neural drive (7). In this context, it 416 
is reasonable to assume that during exercise, alteration of afferent inputs from various 417 
active respiratory muscle groups (which sense tension and displacement) will modulate 418 
dyspnea perception.  The current study design allowed us, for the first time, to evaluate the 419 
sensory consequences of body position-related changes in diaphragmatic efficiency and in 420 
expiratory muscle recruitment in relative isolation, in a setting where intensity of 421 
respiratory neural drive and global contractile respiratory muscle effort was constant. The 422 
finding that intensity, affective and qualitative domains of dyspnea were unaffected by test-423 
specific alterations in respiratory muscle activity required to support a given ventilation 424 
argues against a specific dyspneogenic role for mechanoreceptors in respiratory muscles of 425 
the chest wall and abdomen, at least under the experimental conditions of our study. The 426 
lack of a further increase in dyspnea as a result of greater diaphragmatic dysfunction 427 
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during treadmill walking may reflect the relative paucity of spindles in this muscle, which 428 
provide sensory information about length and displacement (43). The lack of influence of 429 
increased expiratory muscle recruitment on dyspnea during treadmill walking is in keeping 430 
with the results of a recent study, which shows no association between increased 431 
expiratory effort and dyspnea during exercise in COPD (25).  432 
 To the extent that between-test differences in the respiratory muscle activity 433 
required to generate a given ventilation had no measurable effect on dimensions of 434 
dyspnea, it would seem that there is substantial redundancy in the peripheral sensory 435 
systems.  “Sense of effort,” as estimated by Pes,tidal/Pes,max, which was similar at a given 436 
VE during both test modalities, may be more closely linked to amplitude of central corollary 437 
discharge than to the pattern of afferent inputs from contracting respiratory muscles, per se 438 
(6,13,17,24). Thus, afferent inputs from other sources such as pulmonary vagal receptors 439 
and chest wall mechanoreceptors, which are likely similar between tests (given the 440 
similarity of VT and operating lung volumes), may represent the primary source of 441 
peripheral afferent feedback to the somatosensory cortex at least under the current 442 
experimental conditions. 443 
 444 
Limitations 445 
The focus of the current study was to evaluate sensory-mechanical relations in patients 446 
with combined COPD and obesity; therefore, the results may not be generalizable to non-447 
obese patients who are more likely to have reduced resting IC. The lack of measurements of 448 
thoraco-abdominal excursions and tonic and phasic EMG recordings from respiratory 449 
muscles other than the diaphragm precludes definitive conclusions about variability in the 450 
21 
complex respiratory muscle coordination strategies employed as a result of positional 451 
differences during exercise.  452 
 453 
Conclusions and Implications 454 
The current study shows, for the first time, that diaphragmatic and expiratory muscle 455 
activity is different during cycling and walking in obese individuals with COPD. However, 456 
despite the relatively reduced neuromuscular efficiency of the diaphragm during weight-457 
bearing treadmill exercise compared with weight-supported cycling, perceived respiratory 458 
discomfort was not increased. Our results further indicate that exertional dyspnea intensity 459 
is ultimately dictated by the amplitude of respiratory neural drive and concomitant 460 
dynamic restrictive mechanical constraints (decreasing IRV).  Moreover, under conditions 461 
where respiratory neural drive and the volume and timing components of breathing were 462 
constant, body position-related alterations in activity of major respiratory muscles to 463 
achieve a similar ventilation during different exercise modalities had no measurable effects 464 
on the intensity and quality of dyspnea.  465 
Clinicians involved in laboratory cardiopulmonary exercise testing should be aware 466 
of the fundamental physiological differences between cycling and treadmill in obese COPD 467 
patients. Either test modality is suitable for evaluation of dyspnea which, regardless of 468 
physical task, rises in association with increasing central neural drive. An important clinical 469 
implication is that interventions that reduce central respiratory drive (e.g., reduction of 470 
VCO2 by manipulation of energy substrate or exercise training) should successfully relieve 471 
exertional dyspnea in obese patients with COPD. 472 
473 
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FIGURE LEGENDS 606 
Fig 1. (A) ventilation (VE) for a given work rate was similar between cycle and treadmill 607 
exercise. (B) Electrical activation of the diaphragm as a percentage of maximum 608 
(EMGdi/EMGdi,max), (C) esophageal pressure (Pes) swings (inspiration upward), (D) tidal 609 
volume (VT), (E) breathing frequency (fb) and (F) operating lung volumes (inspiration 610 
upward) were similar between exercise modalities and are shown relative to VE. (C) 611 
Maximum inspiratory Pes during an IC maneuver (Pes,IC) was not significantly different 612 
across modalities for pre- and post-exercise measurements when analyzed by two-way 613 
repeated measures ANOVA. EELV: end-expiratory lung volume; EILV: end-inspiratory lung 614 
volume; IRV: inspiratory reserve volume; TLC: total lung capacity. Data are means±SEM.  615 
 616 
Fig 2. Raw data tracings for a representative female patient show mechanical 617 
measurements at the 30 watt load of the cycle and treadmill exercise tests. Despite a 618 
similar ventilation (cycle: 24 L/min treadmill: 26 L/min), tracings show different 619 
respiratory muscle recruitment patterns: inspiratory Pdi was greater during cycling, Pga 620 
was shifted downwards during walking, and the ventilatory muscle recruitment (VMR) 621 
index was more negative during cycling (cycle: -0.67; treadmill: 0.45). Black circles ( ) 622 
represent points of zero flow and connecting bars represent Pga and Pes slopes for the 623 
VMR index calculation. Pes: esophageal pressure; Pga: gastric pressure; Pdi: 624 
transdiaphragmatic pressure; Expir: expiration; Inspir: inspiration. 625 
 626 
Fig 3. (A) Transdiaphragmatic pressure (Pdi), (B) Pdi inspiratory rise (Pdi,insp.rise), (C) 627 
ventilatory muscle recruitment (VMR) index, (D) gastric pressure at zero flow (Pga,zero 628 
27 
flow), (E) expiratory gastric rise (Pga,exp.rise) and (F) the frequency of expiratory muscle 629 
activity are shown relative to work rate. Pdi,IC: maximum inspiratory Pdi during an IC 630 
maneuver; Pga,EE: end-expiratory gastric pressure; Pga,EI: end-inspiratory gastric 631 
pressure. Data are means±SEM unless specified otherwise. *p<0.05 cycle vs treadmill at a 632 
given work rate or at peak exercise. 633 
 634 
Fig 4. The inspiratory rise of transdiaphragmatic pressure (Pdi,insp.rise) is shown relative 635 
to electrical activation of the diaphragm (EMGdi/EMGdi,max). Pdi,insp.rise at 30, 40, 50 636 
EMGdi/EMGdi,max and at peak exercise was significantly greater during cycle compared 637 
with treadmill exercise (*p<0.05). Data are means±SEM.  638 
 639 
Fig 5.  Relationships between dyspnea intensity and (A) ventilation (VE), (C) electrical 640 
activation of the diaphragm as a percentage of maximum (EMGdi/EMGdi,max), and (D) 641 
tidal esophageal pressure swings as a percentage of maximum (Pes,tidal/Pes,max) were 642 
similar between cycle and treadmill exercise. (B) Intensity ratings for unpleasantness of 643 
breathing relative to VE were also similar. Data are means±SEM.  644 
645 
28 
Table 1. Subject Characteristics 646 
Male : Female, n 6 : 6 
Age, yrs 67 ± 8 
Height, cm 167 ± 9 
Weight, kg  103 ± 25  
BMI, kg/m2 36.6 ± 5.4 
Waist circumference, cm:  
Male 134  ± 9 
Female 113 ± 7 
Waist-to-hip ratio:  
Male 1.05 ± 0.07 
Female  0.92 ± 0.07 
Total body fat*, %: 41 ± 2 
     Male (n=4) 40 ± 2 
     Female (n=5) 42 ± 3 
Truncal fat mass*, % total trunk mass: 43 ± 5 
Male (n=4) 45 ± 5 
Female (n=5) 42 ± 5  
Smoking history, pack-years 49 ± 35 
Baseline Dyspnea Index, 0-12 6.5 ± 2.0 
MRC dyspnea scale, 1-5 2.5 ± 0.8 
Pulmonary Function†:  
FEV1, L (% predicted) 1.43 ± 0.44 (60 ± 13) 
FEV1/FVC, % 50 ± 11 
TLC, L (% predicted) 5.67 ± 1.24 (98 ± 10) 
IC, L (% predicted) 2.37 ± 0.85 (89 ± 22) 
FRC, L (% predicted) 3.30 ± 0.83 (105 ± 20) 
RV, L (% predicted) 2.77 ± 0.73 (126 ± 29) 
29 
ERV, L (% predicted) 0.54 ± 0.28 (61 ± 35) 
sRaw, cmH2O•s (% predicted) 16.7 ± 7.9 (397 ± 177) 
DLCO, mL•min-1•mmHg-1 (% predicted) 11.4 ± 4.6 (46 ± 10) 
MIP, cmH2O (% predicted) 68 ±27 (89 ± 36) 
MEP, cmH2O (% predicted) 138 ± 56 (81 ± 22) 
CLst, L/cmH2O 0.27 ± 19 
PLst, cmH2O 20 ± 6 
 647 
Values are means ± SD unless otherwise noted. MRC: Medical Research Council; FEV1: forced 648 
expired volume in 1 second; FVC: forced vital capacity; TLC: total lung capacity;IC: inspiratory 649 
capacity; FRC: functional residual capacity; RV: residual volume; ERV: expiratory reserve volume; 650 
sRAW: specific airway resistance; DLCO: diffusing capacity of the lung for carbon monoxide; MIP: 651 
maximal inspiratory pressure measured at FRC; MEP: maximal expiratory pressure measured at 652 
TLC; CLst: static lung compliance; PLst: static lung recoil pressure. 653 
* Measurements obtained by DEXA scan. 654 
† Pulmonary function test measurements are pre-bronchodilator except forced spirometry 655 
which is post-bronchodilator.  656 
657 
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Table 2. Cardiopulmonary measurements during rest and peak exercise 658 
 Rest Peak 
 Cycle Treadmill Cycle Treadmill 
Work rate, watts 0 ± 0 0 ± 0 73 ± 17 78 ± 22 
Exercise time, mm:ss 0 ± 0 0 ± 0 14:09 ± 3:30 15:13 ± 4:41
Dyspnea, Borg scale 0.1 ± 0.2 0.2 ± 0.2 7.7 ± 2.5 7.1 ± 2.1 
Leg discomfort, Borg 
scale 
0.2 ± 0.3 0.2 ± 0.4 7.6 ± 2.4 5.8 ± 3.1 * 
VO2, L/min 0.44 ± 0.14 0.43 ± 0.17 1.55 ± 0.45 1.74 ± 0.59 *
VO2, % predicted 23 ± 6 21 ± 10 84 ± 22 93 ± 25* 
VCO2, L/min 0.37 ± 0.12 0.34 ± 0.13 1.53 ± 0.40  1.61 ± 0.51 
RER 0.83 ± 0.05 0.81 ± 0.11 0.99 ± 0.08 0.93 ± 0.11 
VE, L/min 15.6 ± 3.7 14.9 ± 4.5 49.0 ± 9.7 49.5 ± 13.0 
VE/MVV, % 35 ± 13 34 ± 13 107 ± 20 109 ± 22 
VE/VCO2 43.9 ±6.0 44.9 ± 8.1 32.9 ± 5.4 31.3 ± 4.7 * 
PETCO2, mmHg 33.6 ± 2.6 33.1 ± 3.2 36.2 ± 5.9 37.5 ± 5.6 * 
VT, L 0.81 ± 0.24 0.81 ± 0.10 1.34 ± 0.36 1.34 ± 0.45 
Fb, breaths/min 21 ± 5 20 ± 6 37 ± 7 38 ± 8 
TI/TTOT 38 ± 5 37 ± 4 40 ± 4 41 ± 5 
IC, L 2.38 ± 0.80 2.37 ± 0.79 1.73 ± 0.34 1.74 ± 0.54 
IRV, L 1.57 ± 0.69 1.56 ± 0.55 0.38 ± 0.15 0.40 ± 0.18 
Heart rate, beats/min 80 ± 8 80 ± 7 120 ± 16 126 ± 18 
Heart rate, % predicted 48 ± 4 48 ± 4 72 ± 9 76 ± 10 
SpO2, % 95 ± 2 95 ± 3 91 ± 3 89 ± 4 * 
 659 
Values are means ± SD.  VO2: oxygen uptake; VCO2: carbon dioxide production; RER: respiratory 660 
exchange ratio; VE: ventilation; MVV: maximal voluntary ventilation; VE /VCO2: ventilatory 661 
equivalent for carbon dioxide production; PETCO2: partial pressure of end-tidal carbon dioxide; VT: 662 
tidal volume; Fb: breathing frequency; TI/TTOT: inspiratory duty cycle; IC: inspiratory capacity; IRV: 663 
inspiratory reserve volume; HR: heart rate; SpO2: arterial oxygen saturation by pulse oximetry.  664 
* p<0.05 treadmill versus cycle test at peak exercise. 665 
666 
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Table 3. Respiratory mechanical measurements during rest and peak exercise 667 
 
Rest Peak 
Cycle Treadmill Cycle Treadmill 
Pdi,sn, cmH2O 88.4 ± 19.6 89.5 ± 24.5 74.7 ± 22.6 65.0 ± 24.8 
Pdi,IC, cmH2O 68.3 ± 23.6 62.0 ± 18.8 49.7 ±15.4 38.8 ± 10.2 
Pes,tidal, cmH2O 9.8 ± 3.6 10.4 ± 4.7 38.3 ± 17.8 37.9 ± 16.3 
Pes,tidal, %Pes,max 9.8 ± 3.3 10.0 ± 4.4 37.9 ± 17.2 36.1 ± 15.8 
VMR index -0.6 ± 0.8 -0.1 ± 0.8* 0.5 ± 0.6 1.2 ± 0.4* 
EMGdi/EMGdi,max, % 18 ± 10 19 ± 9 64 ± 14 72 ± 13* 
Inspiratory muscle activity: 
Pes,insp, cmH2O -7.5 ± 2.2 -6.4 ± 3.4 -16.1 ± 2.2 -15.1 ± 5.2 
Pes,insp, %Pes,IC 28 ± 10 22 ± 8 60 ± 16 71 ± 15 
Pdi,insp, cmH2O 26.7 ± 5.6 24.5 ± 4.9 34.1 ± 7.1 28.9 ± 5.4* 
Pdi,insp, %Pdi,IC 42 ± 15 43 ± 14 71 ± 13 74 ± 10 
Pdi,insp.rise, cmH20 10.0 ± 3.9 8.0 ± 2.8* 11.5 ± 6.1 8.3 ± 3.9* 
Expiratory muscle activity: 
Pes,exp, cmH2O 2.3 ± 2.8 4.0 ± 2.3* 22.2 ± 15.2 22.8 ± 13.1 
Pga,exp, cmH2O 20.2 ± 4.9 19.7 ± 4.3 37.0 ± 17.8 37.5 ± 13.7 
Pga,exp rise, cmH2O 2.3 ± 1.6 3.4 ± 2.5 22.3 ± 17.8 27.0 ± 16.6* 
Pga,EI, cmH2O 19.5 ± 5.0 18.2 ± 4.6 17.7 ± 6.2 10.1 ± 4.2* 
Pga,EE, cmH2O 16.6 ± 3.3 16.0 ± 6.8 26.8 ± 8.5 27.4 ± 6.9 
 668 
Values are means ± SD. See text for abbreviations. 669 
*p<0.05 treadmill versus cycle exercise at that measurement point. 670 
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